Following the COVID-19 virus epidemic, extensive, coordinated international research has
led to the rapid development of effective vaccines. Although vaccines are now considered …

Purpose of Review A variety of neurological complications have been reported following the
widespread use of the COVID-19 vaccines which may lead to vaccine hesitancy and serve …

Objective This study aimed to retrospectively analyze reported Guillain–Barré syndrome
(GBS) cases that occurred after COVID-19 vaccination. Methods Case reports of GBS …

According to the WHO, as of January 2023, more than 850 million cases and over 6.6 million
deaths from COVID-19 have been reported worldwide. Currently, the death rate has been …

Introduction Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) became a
major concern since the announcement that it is a pandemic in early 2020. Vaccine trials …

Background and Objectives There are concerns on the safety of SARS-CoV-2 vaccination in
patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory …

Despite the advantages of getting access to the coronavirus disease 2019 (COVID-19)
vaccines, their potential ability to induce severe adverse events (AEs) has been a significant …

Guillain-Barré syndrome (GBS) is a rare but serious immune-mediated neurological
condition characterized by damage to the peripheral nervous system. Two-thirds of cases of …

Purpose An association between Guillain-Barré syndrome (GBS) and severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination has been reported. We …

Accumulating evidence in the third year of the global pandemic suggests that coronavirus
disease 2019 (COVID-19) can cause neuromuscular complications during or after the acute …